Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 215 - Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
Patents for C07D 215 - Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems (27,676)
12/2009
12/16/2009CN101605762A Novel 1,2-dihydroquinoline derivative having substituted phenylamino lower alkyl group and ester-introduced phenyl group as substituents
12/16/2009CN101602724A 4,4'-bis(5-sulfo-8-hydroxyl-7-aminoquinoline azo)-3,5,3',5'-tetrabromo-diphenyl ether
12/16/2009CN101602723A Preparation method of 2-methyl-8-aminoquinoline
12/16/2009CN101602687A 6-nitroacetophenone compound, preparation method and application thereof
12/16/2009CN100569769C Compounds with antibacterial activity
12/16/2009CN100569753C A crystalline of 4-(3-chloro-4-(cyclopropylaminocarbonyl)aminophenoxy)-7-methoxy-6-quinolinecarboxamide methanesulfonate a process for preparing the same
12/16/2009CN100569734C Organic compound containing heteroatoms and its use in Zigler-Natta catalyst
12/15/2009US7632865 N-(4-(3-chloro-5-trifluoromethyl-2-pyridyloxy)phenyl)-2-chloro-5-nitrothiobenzamide, for example; useful as preventive or therapeutic medicines for diseases accompanied by hyperactivated immune functions
12/15/2009US7632850 2-amino-2-oxoethyl 1-(4'-fluoro-1,1'-biphenyl-4-yl)cyclopropylmethylcarbamate and 2-(methylamino)-2-oxoethyl 1-(4'-fluoro-1,1'-biphenyl-4-yl)cyclopropylmethylcarbamate; fatty acid amide (FAAH) hyrdrolase inhibitors; analgesics; neuropathic pain;psychological disorders; anticarcinogenic agents; AIDS
12/15/2009US7632846 Hexenoic acid derivatives, processes for the preparation thereof, pharmaceutical compositions comprising them, and therapeutic applications thereof
12/15/2009US7632845 Phenyl quinolines and their use as estrogenic agents
12/15/2009US7632783 fungicides, pesticides for protecting rice crop, tomatoes, cucumbers and green beans; 3-(5-fluoro-3,3-dimethyl-3,4-dihydroisoquinolin-1-yl)quinoline
12/15/2009CA2373180C Propanoic acid derivatives that inhibit the binding of integrins to their receptors
12/10/2009WO2009148659A2 Antimalarial quinolines and methods of use thereof
12/10/2009WO2009148004A1 Novel compound and pharmaceutical application of same
12/10/2009WO2009147616A1 [4-(1-amino-ethyl) -cyclohexyl] -methyl-amine and [6-(1-amino-ethyl) -tetrahydro- pyran-3-yl] -methyl-amine derivatives as antibacterials
12/10/2009WO2009146546A1 8-hydroxyquinoline derivatives for the treatment of hematological malignancies
12/10/2009US20090306133 New Acetyl Coenzyme A Carboxylase (ACC) Inhibitors And Uses In Treatments Of Obesity And Diabetes Mellitus - 087
12/10/2009US20090306112 Antiviral protease inhibitors
12/10/2009US20090306085 Hcv protease inhibitors and uses thereof
12/10/2009US20090300856 Specific monocationic monochromophoric compounds of hydrazone type comprising a 2-, 4-pyridinium or 2-, 4-quinolinium unit, synthesis thereof, dye compositions containing them, and method for dyeing keratin fibres
12/10/2009CA2726537A1 8-hydroxyquinoline derivatives for the treatment of hematological malignancies
12/10/2009CA2725616A1 [4-(1-amino-ethyl) -cyclohexyl] -methyl-amine and [6-(1-amino-ethyl) -tetrahydro- pyran-3-yl] -methyl-amine derivatives as antibacterials
12/09/2009EP2130827A1 Method for producing quinolone carboxylic acid derivative
12/09/2009EP2130820A1 Antipruritics
12/09/2009EP2129661A1 Quinoline derivatives as crth2 receptor ligands
12/09/2009EP1182183B1 Anthracene derivatives and organic electroluminescent devices made by using the same
12/09/2009CN101600694A Composition for treatment of undifferentiated-type of gastric cancer
12/09/2009CN101597259A Organic material and application thereof in organic electroluminescence device (OELD)
12/09/2009CN100567289C 2-(hetero)aryl substituted tetrahydroquinoline derivatives
12/09/2009CN100567279C Derivatives of alkylpiperazine- and alkylhomopiperazine-carboxylates, preparation method thereof and use of same as FAAH enzyme inhibitors
12/09/2009CN100567265C Organometallic complexes and organic electroluminescence device using the same
12/08/2009US7629468 Neuroprotectants, analgesics or anticonvulsants
12/08/2009US7629467 Diphenyl substituted cycloalkanes, compositions containing such compounds and methods of use
12/08/2009US7629363 Diaryl substituted pyridinones
12/08/2009US7629337 Chemokine receptor binding heterocyclic compounds
12/08/2009CA2422342C Novel amide derivatives and medicinal use thereof
12/08/2009CA2399802C Tocopherols, tocotrienols, other chroman and side chain derivatives and uses thereof
12/03/2009WO2009144742A2 An improved process for preparing montelukast and salts thereof
12/03/2009WO2009144407A1 Salts of 2-substituted quinolines
12/03/2009WO2009095872A3 Labelled analogues of halobenzamides as multimodal radiopharmaceuticals and their precursors
12/03/2009US20090299065 Process for the manufacture of organic compounds
12/03/2009US20090298872 Compounds and compositions as modulators of steroidal receptors and calcium channel activities
12/03/2009US20090298841 serotonin receptor modulators such as 8-(4-Methyl-piperazin-1-yl)-3-phenylsulfonylquinoline, used for treating obesity, nervous system disorders such as dementia, schizophrenia and Alzheimer's disease, and as cognition activators
12/03/2009US20090298827 Novel 1,2-dihydroquinoline derivative having substituted phenylamino lower alkyl group and ester-introduced phenyl group as substituents
12/03/2009US20090298826 Novel 1,2-dihydroquinoline derivative having (substituted phenyl or substituted heterocyclic) carbonyloxy lower alkyl group and ester-introduced phenyl group as substituents
12/02/2009EP2128134A1 Sulfonylurea derivative capable of selectively inhibiting mmp-13
12/02/2009EP2125777A1 Spiro substituted compounds as angiogenesis inhibitors
12/02/2009EP1791820B1 Enantioselective preparation of quinoline derivatives
12/02/2009EP1622875B1 Crystalline forms of an arylaniline beta-2 adrenergic receptor agonist
12/02/2009EP1392683B1 Substituted 4h-chromenes and analogs as activators of caspases and inducers of apoptosis and their use as anticancer agents
12/02/2009CN101595101A Quinolone carboxylic acids, derivatives thereof, and methods of making and using same
12/02/2009CN101591291A Synthesis method of 2-ethenyl quinoline compound
12/02/2009CN101591290A Back-end production process for synthesizing quinoline and derivative thereof
12/02/2009CN100564377C Substituted 4H-chromenes and analogs as activators of caspase and inducers of apoptosis and use thereof
12/01/2009US7626035 Optically active, heteroaromatic β-hydroxy esters and processes for their preparation from β-keto esters and processes for the preparation of these β-keto esters
12/01/2009US7626033 Compounds for the modulation of PPARγ activity
12/01/2009US7626032 4-Amino-3,3-dimethylpiperidine; reduced toxicity, and improved pharmacology and pharmacokinetics
12/01/2009US7626030 Compounds and methods of use
12/01/2009US7626029 Into a difluorobenzoic acid, for producting quinolonecarboxylic acid serving as synthetic antibacterial agent, medicament, agricultural chemical, or veterinary drug; ionic liquid solvents
12/01/2009US7626028 Use of quinaldine and naphthaline derivatives as crystallisation modifiers
12/01/2009US7625906 Fused-aryl and heteroaryl derivatives as modulators of metabolism and the prophylaxis and treatment of disorders related thereto
12/01/2009CA2389412C N-guanidinoalkylamides, their preparation, their use, and pharmaceutical preparations comprising them
12/01/2009CA2264556C Substituted n-[(aminoiminomethyl or aminomethyl)phenyl]propyl amides
11/2009
11/26/2009WO2009143246A2 Arylsulfonamide compounds, compositions and methods of use
11/26/2009WO2009143178A2 Pde10 inhibitors and related compositions and methods
11/26/2009WO2009141386A1 Derivatives of quinolines and quinoxalines as protein tyrosine kinase inhibitors
11/26/2009WO2009140765A1 Selective caspase inhibitors and uses thereof
11/26/2009WO2009120774A3 Method of preparing huperzine a and derivatives thereof
11/26/2009US20090292125 process for preparing tetrahydroquinoline derivatives
11/26/2009US20090291956 SALTS OF 2-FLUORO-N-METHYL-4-[7-(QUINOLIN-6-YL-METHYL)-IMIDAZO[1,2-b][1,2,4]TRIAZIN-2-YL]BENZAMIDE AND PROCESSES RELATED TO PREPARING THE SAME
11/26/2009US20090291950 Bicyclic heteroaryl inhibitors of pde4
11/26/2009US20090291948 Sulfonamide peri-substituted bicyclics for occlusive artery disease
11/26/2009US20090291904 Chemical derivatives of jasmonate, pharmaceutical compositions and methods of use thereof
11/26/2009CA2725185A1 Derivatives of quinolines and quinoxalines as protein tyrosine kinase inhibitors
11/26/2009CA2724785A1 Selective caspase inhibitors and uses thereof
11/25/2009EP2121616A1 Novel 4-amino-quinoline derivatives useful as anti-malaria drugs
11/25/2009EP2121615A1 Napadisylate salt of 5-(2-{[6-(2,2-difluoro-2-phenylethoxy)hexyl]amino}-1-hydroxyethyl)-8-hydroxyquinolin-2(1h)-one as agonist of the beta 2 adrenergic receptor
11/25/2009EP2120911A1 Amide and urea derivatives for the treatment of metabolic diseases
11/25/2009EP0931060B1 Substituted n- (aminoiminomethyl or aminomethyl)phenyl propyl amides
11/25/2009CN101589026A Method of treatment of glioma brain tumour
11/25/2009CN101585808A Method for asymmetric catalytic hydrogenation of quinoline derivatives
11/25/2009CN100562516C Beta-amyloid protein production/secretion inhibitors
11/25/2009CN100562513C Benzamide derivative or salt thereof
11/24/2009US7622585 Useful as selective inhibitors of serine protease enzymes of the coagulation cascade; for example thrombin, factor VIIa, factor Xa, factor XIa, factor IXa, and/or plasma kallikrein; 2-(1-aminoisoquinolin-6-ylamino)-2-(3-ethoxy-4-isopropoxyphenyl)-l -(2-phenylpyrrolidin-1-yl)ethanone, for example
11/24/2009US7622484 Such as asthma or chronic obstructive pulmonary disease; a corticoid such as mometasone furoate and 5-(1-hydroxy-2-((5,6-diethylindan-2-yl)amino)ethyl)8-hydroxy-1,2-dihydroquinolin-2-one or salt such as maleate
11/24/2009US7622483 Administering an aminoindanyl derivative and; a steroid, dopamine receptor agonist or an anticholinergic or antimuscarinic agent; respiratory system disorders, antiallergens, chronic obstructive pulmonary disease, adult respiratory distress syndrome, bronchitis
11/24/2009US7622467 Aryl aniline derivatives as β2 adrenergic receptor agonists
11/24/2009CA2578326C Alkynyl-substituted quinolin-2-one derivatives useful as anticancer agents and intermediates thereof
11/24/2009CA2448421C Process for producing quinoline carbaldehyde
11/24/2009CA2385882C Tyrosine derivatives
11/19/2009WO2009139373A1 Amide compound
11/19/2009WO2009139361A1 Glucocorticoid receptor agonist composed of 2,2,4-trimethyl-6-phenyl-1,2-dihydroquinoline derivative having substituted oxy group
11/19/2009WO2009138993A1 A process for preparation of montelukast sodium salt
11/19/2009WO2009089537A3 Anti-cancer compounds
11/19/2009US20090286828 2-amino-1-phenylethylcarboxamide derivatives
11/19/2009US20090286814 Hcv protease inhibitors
11/19/2009US20090286776 Hexenoic acid derivatives, processes for the preparation thereof, pharmaceutical compositions comprising them, and therapeutic applications thereof
11/19/2009US20090285849 Thiosemicarbazones as anti-virals and immunopotentiators
11/19/2009US20090285772 Quinoline derivatives for modulating dna methylation
1 ... 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66 67 68 69 ... 277